Xiuling Lu has attained the esteemed title of AAPS Fellow, a recognition of her steadfast commitment to pioneering research, marked by its unwavering excellence and innovation, and the transformative effects it has had on patients grappling with unmet medical needs.

An AAPS Fellow is an AAPS member who is recognized as a leader in the pharmaceutical field. Peers recognize Fellows for facing challenges head-on with creative solutions in the discovery, development or regulation of pharmaceuticals and biologics.

The status of Fellow denotes professional excellence and a sustained, positive impact to global health and to the AAPS Community. AAPS Fellows are encouraged to continue to actively contribute to their fields and to AAPS throughout their tenure.

Lu stands as a distinguished luminary in the realm of nanoparticle-based therapeutics and their corresponding product advancement. At UConn, her lab has successfully devised inventive image-guided therapeutic nanoparticle systems, surmounting considerable obstacles within the realm of cancer treatment. Lu’s contributions extend further to a profound comprehension of the challenges associated with designing therapeutic agents, enhancing the bedrock understanding of delivery and treatment barriers.

Lu’s engagement encompasses not only the translation of prospective therapeutics to clinical applications but also the commercialization of nanomedicines. Her resolute dedication to scientific advancement and her altruistic endeavors within the community have merited her a multitude of local and national accolades. Lu has served of Chair of the Faculty at the National Institute for Pharmaceutical Technology and Education, and presently holds the mantle of Associate Director at the Center for Pharmaceutical Processing Research, concurrently serving as a leader in the AAPS Nanotechnology Community.